Delcath Systems, Inc. - Common Stock (DCTH)
16.30
+0.05 (0.31%)
Delcath Systems Inc is a medical technology company focused on the development and commercialization of innovative therapeutic systems for the treatment of cancer
The company's primary product is a specialized delivery system designed to administer high doses of chemotherapy directly to tumors while reducing systemic exposure and associated side effects. Through its proprietary techniques, Delcath aims to improve treatment outcomes for patients suffering from various types of cancer, particularly liver cancers, by enhancing the efficacy and safety of cancer therapies. The company is dedicated to advancing its technologies and expanding its clinical applications to better serve oncologists and patients in the fight against cancer.
Frequently Asked Questions
Is Delcath Systems, Inc. - Common Stock publicly traded?
Yes, Delcath Systems, Inc. - Common Stock is publicly traded.
What exchange does Delcath Systems, Inc. - Common Stock trade on?
Delcath Systems, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Delcath Systems, Inc. - Common Stock?
The ticker symbol for Delcath Systems, Inc. - Common Stock is DCTH on the Nasdaq Stock Market
What is the current price of Delcath Systems, Inc. - Common Stock?
The current price of Delcath Systems, Inc. - Common Stock is 16.30
When was Delcath Systems, Inc. - Common Stock last traded?
The last trade of Delcath Systems, Inc. - Common Stock was at 4:00 pm EST on February 5th, 2025
What is the market capitalization of Delcath Systems, Inc. - Common Stock?
The market capitalization of Delcath Systems, Inc. - Common Stock is 128.88M
How many shares of Delcath Systems, Inc. - Common Stock are outstanding?
Delcath Systems, Inc. - Common Stock has 7.91M shares outstanding.